-
Mashup Score: 5Lp(a) Therapeutics in Development – New Medications in the Armamentarium for ASCVD? - 9 month(s) ago
Home > CardioNerds > Lp(a) Therapeutics in Development – New Medications in the Armamentarium for ASCVD? Elevated lipoprotein (a) [Lp(a)] is an established risk factor for atherosclerotic cardiovascular disease (ASCVD), as demonstrated in several epidemiological, genome-wide association, and Mendelian randomization studies (1-3). However, to date, there are no available therapies that lead to a substantial reduction in Lp(a) and no clinical trial data to support that lowering Lp(a) reduces adverse cardiovas
Source: www.docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 2Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension | NEJM - 9 month(s) ago
Original Article from The New England Journal of Medicine — Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Source: www.nejm.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
We hope you enjoyed this journal club as much as we did and looking forward to the next! #CardioNerds Please joing us next month to discuss STELLAR trial https://t.co/hYErIqbMRN Follow us for the date to be decided!!
-
-
Mashup Score: 1#CardsJC: Chronic Hypertension and Pregnancy - CHAP Trial - Cardionerds Twitter Journal Club - 1 year(s) ago
CardioNerds #CardsJC focuses Chronic Hypertension and Pregnancy – CHAP Trial
Source: CardionerdsCategories: Cardiologists, Latest HeadlinesTweet-
4) Change in HTN targets in pregnancy w/ recent data #ACC23/#WCCCardio #CardioNerds CHAP trial ➡️ also check out #CardsJC with @CardioNerdsJC https://t.co/x304rg8zsa https://t.co/HrHqr9hUis
-
-
Mashup Score: 5227. CCC: Positive Ventilation in the CICU with Dr. Sam Brusca, Dr. Chris Barnett, and Dr. Burton Lee - 1 year(s) ago
The CardioNerds Cardiac Critical Care Series continues with a discussion about Positive Ventilation in the CICU with Dr. Sam Brusca, Dr. Chris Barnett, and Dr. Burton Lee
Source: CardionerdsCategories: Cardiologists, Latest HeadlinesTweet-
Respiratory support in the CICU - great talk by @carlosalviar 🔺respiratory failure is most common cause of admission to CICU Also check out the @CardioNerds episode on PPV in CICU: https://t.co/VLZsvypZ1B #ACC23/#WCCCardio #CardioNerds https://t.co/wyRr8dxBMI
-
-
Mashup Score: 0
These data underscore the risks associated with the provision of renal support in patients with primary cardiovascular problems and the need to develop standardized indications and potential futility measures in this specialized population.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
Great talk on renal strategies in the CICU by @ShashankSinhaMD Data from CCTN 🔺Pts in CICU with renal failure had 3 fold ⬆️ risk of in-hospital mortality 🔺10 fold inter-hospital difference in the use of acute RRT https://t.co/8BZQpSNEcp #ACC23/#WCCCardio #CardioNerds https://t.co/q0XPWvBd2c
-
-
Mashup Score: 3
The CardioNerds Cardiac Critical Care Series continues with a discussion about the Approach to Renal Replacement Therapy in the CICU with Dr. Joel Topf
Source: CardionerdsCategories: Expert Picks, Latest HeadlinesTweet-
@CardioNerds @GavHick @MarkBelkinMD @EuniceDuganMD @karanpdesai @YoavKarpenshif @JasonKatzMD @dranulala @ShashankSinhaMD @AnnGageMD @AndrewHigginsMD @noshreza @KBerlacher @vbluml @nikolhaustweets @robmentz @DrMarthaGulati @AshishCorrea @agtruesdell @NatalieTapaskar @RyanTedfordMD @pablosanchezcas @NavinKapur4 @BurkhoffMd @JuliettePower44 @meganfburke @KatieV_MD @david_furfaro @kofi_larry @SarahChuzi @WeAreNUHeart @docbfreed @melsulistio @rachkataria @captainchloride @ElliottMillerMD @msdmsdoms 🚨@CardioNerds Cardiac Critical Care Series🚨 A ubiquitous treatment may #CardioNerds could use a refresher on... #264. Approach to Renal Replacement Therapy w/ @kidney_boy @TomioTran 🔗https://t.co/J3QK8lM4DW @MarkBelkinMD @EuniceDuganMD @karanpdesai @YoavKarpenshif https://t.co/aXSNVdH4HT
-
-
Mashup Score: 3First Randomized Study on Cardioneuroablation Shows Promise - 1 year(s) ago
Reflex vasovagal syncope (VVS) is the most common cause of transient loss of consciousness.1 Despite its benign course, many patients experience recurrent
Source: Docwire NewsCategories: Expert Picks, Latest HeadlinesTweet-
First Randomized Study on #Cardioneuroablation Shows Promise https://t.co/kmX7NMB1KM via @mydocwire @CardioNerds @CardioNerdsJC #docwirenews #CardioNerds
-
RT @mydocwire: First Randomized Study on #Cardioneuroablation Shows Promise https://t.co/kmX7NMB1KM via @mydocwire @CardioNerds @CardioNerd…
-
-
Mashup Score: 19Cardio-Oncology Series Page - CardioNerds - 2 year(s) ago
The CardioNerds Cardio-Oncology series provides a comprehensive curriculum with the aim of bringing every CardioNerd up on all things related to cardiooncology.
Source: CardionerdsCategories: Expert Picks, Latest HeadlinesTweet-
RT @CardioNerds: 🎙️📢 @CardioNerds launches the: 🫀 #CardioNerds #CardioOncology Series‼️ 🔗https://t.co/ptbbcUogJ7 Led by Co-Chairs: @dinu…
-
-
Mashup Score: 7Atlas of Cardiac Anatomy gratis eBook — Cardiotext Publishing - Cardiology Books and eBooks - 2 year(s) ago
This PDF is free of charge and may be downloaded by registering here. Please note credit card information is NOT required at checkout.
Categories: Expert Picks, Latest HeadlinesTweet-
#CardioNerds, check out this Atlas of Cardiac Anatomy by Drs. Shumpei Mori and Kalyanam Shivkumar @shivkumarmd Open access with terrific dissections, images, and illustrations. 🔗https://t.co/i3SSU8ozft
-
-
Mashup Score: 16Cardio-Oncology Series Page - CardioNerds - 2 year(s) ago
The CardioNerds Cardio-Oncology series provides a comprehensive curriculum with the aim of bringing every CardioNerd up on all things related to cardiooncology.
Source: CardionerdsCategories: Cardiologists, Latest HeadlinesTweet-
RT @CardioNerds: 🎙️📢 @CardioNerds launches the: 🫀 #CardioNerds #CardioOncology Series‼️ 🔗https://t.co/ptbbcUogJ7 Led by Co-Chairs: @dinu…
-
The @Cardionerds review news from the @ASPCardio 2023 Congress on lipoprotein (a) therapeutics, an evolving class of agents being explored in patients with atherosclerotic cardiovascular diseases. https://t.co/nu7VBceRkW #ASPC2023 #Cardionerds https://t.co/l0Y8ghpSCW